A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR

NCT00368069 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: Keppra® extended release formulation - XR
DRUG: Placebo

Sponsor

UCB Pharma